Article (Périodiques scientifiques)
Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity.
HOLUKA, Cyrielle; Snoeck, Chantal J.; Mériaux, Sophie B. et al.
2021In Journal of Clinical Medicine, 10 (10)
Peer reviewed vérifié par ORBi
 

Documents


Texte intégral
jcm-10-02159-v3_Adverse.pdf
Postprint Éditeur (1.59 MB)
Article
Télécharger

Open Access


Tous les documents dans ORBilu sont protégés par une licence d'utilisation.

Envoyer vers



Détails



Mots-clés :
COVID-19; SARS-CoV-2; adult traumatic events; early-life adversity; psychosocial adversity; relative risk; serology
Résumé :
[en] Asymptomatic individuals, called "silent spreaders" spread SARS-CoV-2 efficiently and have complicated control of the ongoing COVID-19 pandemic. As seen in previous influenza pandemics, socioeconomic and life-trajectory factors are important in disease progression and outcome. The demographics of the asymptomatic SARS-CoV-2 carriers are unknown. We used the CON-VINCE cohort of healthy, asymptomatic, and oligosymptomatic individuals that is statistically representative of the overall population of Luxembourg for age, gender, and residency to characterise this population. Gender (male), not smoking, and exposure to early-life or adult traumatic experiences increased the risk of IgA seropositivity, and the risk associated with early-life exposure was a dose-dependent metric, while some other known comorbidities of active COVID-19 do not impact it. As prior exposure to adversity is associated with negative psychobiological reactions to external stressors, we recorded psychological wellbeing during the study period. Exposure to traumatic events or concurrent autoimmune or rheumatic disease were associated with a worse evolution of anxiety and depressive symptoms throughout the lockdown period. The unique demographic profile of the "silent spreaders" highlights the role that the early-life period plays in determining our lifelong health trajectory and provides evidence that the developmental origins of health and disease is applicable to infectious diseases.
Disciplines :
Neurosciences & comportement
Auteur, co-auteur :
HOLUKA, Cyrielle 
Snoeck, Chantal J.
Mériaux, Sophie B.
OLLERT, Markus ;  University of Luxembourg
KRÜGER, Rejko ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Translational Neuroscience
TURNER, Jonathan ;  University of Luxembourg > Faculty of Science, Technology and Communication (FSTC)
The Con-Vince Consortium
Co-auteurs externes :
no
Langue du document :
Anglais
Titre :
Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity.
Date de publication/diffusion :
2021
Titre du périodique :
Journal of Clinical Medicine
eISSN :
2077-0383
Maison d'édition :
MDPI, Basel, Suisse
Volume/Tome :
10
Fascicule/Saison :
10
Peer reviewed :
Peer reviewed vérifié par ORBi
Focus Area :
Systems Biomedicine
Projet FnR :
FNR14716281 - 2020 (01/04/2020-30/09/2022) - Rejko Krueger
Disponible sur ORBilu :
depuis le 14 février 2022

Statistiques


Nombre de vues
149 (dont 17 Unilu)
Nombre de téléchargements
63 (dont 2 Unilu)

citations Scopus®
 
0
citations Scopus®
sans auto-citations
0
OpenCitations
 
0
citations OpenAlex
 
0
citations WoS
 
0

Bibliographie


Publications similaires



Contacter ORBilu